• No results found

Subcellular Localization and Functional Characterization of GII.4 Norovirus-Encoded NTPase

N/A
N/A
Protected

Academic year: 2019

Share "Subcellular Localization and Functional Characterization of GII.4 Norovirus-Encoded NTPase"

Copied!
21
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

FIG 1 Expression and subcellular localization of six nonstructural proteins from a GII.4 HuNV strain
FIG 2 Nonvesicular fraction of GII-NTPase significantly localizes to the ER or mitochondria in cells
FIG 3 N-terminal 179-aa region of GII-NTPase is required for vesicle formation and ER colocalization
FIG 4 C-terminal region of GII-NTPase is involved in mitochondrial targeting. (A) Diagram of the full length and deletionconstructs of F-NTPase
+7

References

Related documents

The aim of the present study was to further investigate the associations between sex, clinical data, type, severity and prevalence of cardinal symptoms suggestive of gas- troparesis

(2014), Accounts receivables management and financial performance of manufacturing firms in Nakuru County, Kenya , unpublished manuscript, school of business, university of

The evolution of initial rectangular pulses of dust sound waves in the cylindrical plasma waveguides with di- electrics has demonstrated the essential surface nonlinearity near

Brown dashed line – model output produced assuming initial fluxes at 50 % steady state values, variable pyrite burial, fixed weathering fluxes and 1 pyr... Sensitivity

How might the “ audio compression ” hypothesis be put to a rigorous test. First of all, it is imperative that a for- mal, exhaustive and statistically robust comparison of

This study aimed at identifying the level of depression and sense of insecurity among a sample of female refugee adolescents, and the impact of correcting cognitive distortions

There would be significant difference among students of VII, VIII and IX class students of selected Secondary schools of Kalluru mandal with regard to their Emotional

The primary objective of the BATTLE trial is to dem- onstrate the clinical superiority of primary stenting using the Zilver® PTX® stent system versus a latest generation bare